The funding round was led by Target Global with participation from ENERN Investments and EBRD while the merger with Doctoralia will make DocPlanner the largest medical booking platform globally, according to the announcement.
The merged company now has 15 million users and five million health professionals in 25 countries. Doctoralia had a particularly strong presence in its native Spain and in Latin America.
Doctoralia’s founder will become shareholders in the merged company and join the senior management team.
“The companies have complementary geographies and great teams. By joining forces we can leverage best practices and provide an even better software and product offering for both doctors and patients on a truly global scale,” said Mariusz Gralewski, CEO of DocPlanner.
“We are thrilled to build a global healthcare leader with DocPlanner, especially that the teams share similar attitudes and there is so much we can learn from each other; we could not have asked for a better partner,” added Doctoralia CEO Albert Armengol.
This latest round brings DocPlanner’s total funding to $34 million. It raised a $10 million Series B last year.